Hvad er Y-tunnus-nummeret på CH-Bioforce Oy?

CH-Bioforce Oy er registreret hos PRH / YTJ under Y-tunnus 2739534-8.

Hvad er omsætningen for CH-Bioforce Oy?

CH-Bioforce Oy rapporterede en omsætning på EUR 33K i 2025.

Hvor mange medarbejdere har CH-Bioforce Oy?

CH-Bioforce Oy beskæftiger 9 personer pr. seneste årsrapport.

Hvem er administrerende direktør i CH-Bioforce Oy?

Tapani Esa Niskanen er Chief Executive Officer i CH-Bioforce Oy, i rollen siden 2024.

Hvem er bestyrelsesformand i CH-Bioforce Oy?

Mikko Juhani Maijala er bestyrelsesformand i CH-Bioforce Oy, i rollen siden 2016.

Hvor har CH-Bioforce Oy hovedsæde?

CH-Bioforce Oys registrerede adresse er Tekniikantie 4-C31.

Riskpilot← Tilbage til søgning

Log indFå fuld adgang

CH-Bioforce Oy

OYActive

Y-tunnus 2739534-8Tekniikantie 4C-431, 02150 EspooManufacture of other chemical products n.e.c. · NACE 2059Est. 20169 employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2021	2022	2023	2024	2025
Revenue	166	212	86	129	33
Staff expenses	−667	−804	−786	−821	−1 040
EBITDA	−440	−979	−679	−1 326	−1 667
Depreciation & amort.	−376	−408	−261	−150	−121
EBIT	−816	−1 387	−941	−1 476	−1 788
Net financials	−133	−288	−247	−299	−412
Profit before tax	−949	−1 675	−1 187	−1 775	−2 200
Tax	−0	−0	−0	−0	−0
Net profit	−949	−1 675	−1 187	−1 775	−2 200

Balance sheet

EUR thousands

Item	2021	2022	2023	2024	2025
Total assets	928	547	596	2 495	2 066
Equity	−1 375	337	−4 237	−4 237	−4 737
Long-term debt	1 823	—	4 287	4 287	4 787
Short-term debt	480	210	546	546	3 041
Total debt	2 304	210	4 833	4 833	7 828

Financial ratios

5-year trend

EBITDA-margin

-5017.7%

This company

15.8%

Market median

-31858% vs market

20212025

Soliditetsgrad

-229.3%

This company

38.2%

Market median

-700% vs market

20212025

Egenkapitalforrentning

-220000000.0%

This company

18.4%

Market median

-1195652274% vs market

20212025

Nettoresultatgrad

-6620.7%

This company

8.1%

Market median

-81837% vs market

20212025

Aktivomsætning

0.02×

This company

1.12×

Market median

-98% vs market

20212025

Gæld/egenkapital

1.44×

This company

0.62×

Market median

-132% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2024-06-01 – 2025-05-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-06-01 – 2024-05-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-06-01 – 2023-05-31
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-06-01 – 2022-05-31
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-06-01 – 2021-05-31
View PDF

CH-Bioforce Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on CH-Bioforce Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on CH-Bioforce Oy